<DOC>
	<DOCNO>NCT00474019</DOCNO>
	<brief_summary>The purpose research study evaluate much repeat daily intravenous ( IV , mean vein ) dose esomeprazole get bloodstream hospitalize child age 0-17 year old require acid suppression therapy .</brief_summary>
	<brief_title>Phase 1 Pharmacokinetics Intravenous Nexium Children</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>parent/guardian must sign consent form child ask sign Assent Form he/she old enough able sign verbal assent acceptable child old enough understand , unable write female and/or male hospitalized patient age 017 year old consider treatment acid suppressive therapy . female patient pregnant , plan become pregnant study period breastfeed child patient history multiple drug allergy illness , medical history , abnormal laboratory value , abnormal physical examination finding abnormal vitals sign could put patient risk participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>pediatrics</keyword>
	<keyword>neonate</keyword>
</DOC>